stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / AVR

Anteris Technologies Global Corp. (AVR)

Healthcare · Medical Instruments & Supplies · NasdaqGM

Price
$9.28
Market Cap
$903.34M
P/E Ratio
0.00
EPS
$-2.22
Sector
Healthcare
52-Week High
$10.14
52-Week Low
$2.85
Dividend Yield

Anteris Technologies Global Corp. revenue & earnings — last 5 fiscal years

Metric20212022202320242025
Revenue$5.83M$3.20M$2.73M$2.70M$1.91M
Gross profit$1.91M$298,383$876,800$1.27M$1.34M
Net income$-17.17M$-30.56M$-46.02M$-76.29M$-94.14M
Net margin-294.5%-954.9%-1682.8%-2822.5%-4921.3%

Source: Anteris Technologies Global Corp. SEC filings (10-K).

Explore 5 years of Anteris Technologies Global Corp. financials — interactive

Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.

Open the interactive view — free

Or start a 7-day free trial to track AVR in your portfolio →

Anteris Technologies Global Corp. financial history by metric

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Anteris Technologies Global Corp. — frequently asked questions

What is Anteris Technologies Global Corp.'s revenue?

Anteris Technologies Global Corp. (AVR) reported revenue of $1.91M for fiscal year 2025, down 29.2% from the prior year, according to its SEC filings.

Is Anteris Technologies Global Corp. profitable?

No — AVR reported a net loss of $-94.14M in fiscal 2025.

What is AVR's P/E ratio?

Anteris Technologies Global Corp. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.

How fast is Anteris Technologies Global Corp. growing?

AVR's revenue grew at roughly -24.3% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.

How much debt does Anteris Technologies Global Corp. have?

As of fiscal year 2025, AVR carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.

What is Anteris Technologies Global Corp.'s gross margin?

AVR's gross margin was 70.3% in fiscal 2025 — gross profit of $1.34M on revenue of $1.91M.

What is Anteris Technologies Global Corp.'s market cap?

Anteris Technologies Global Corp. (AVR) has a market capitalization of about $903.34M, based on the latest data in our nightly-refreshed cache.

When does Anteris Technologies Global Corp.'s fiscal year end?

AVR's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.

Where does this data come from?

All figures are computed from Anteris Technologies Global Corp.'s official SEC filings (10-K and 10-Q), covering 5 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.

Explore more stocks

Browse all 1,500+ companies → · Screen them by fundamentals →